Sharklet Technologies
Latest round
- Series B
Last raised
- Dec 2012
Total raised
- $3.5M
Investors
- 2
About Sharklet Technologies
Established in 2007 and based in Beijing, China,Sharklet Technologies, Inc. operates as a biotechnology company that develops and markets surface technologies for bacterial inhibition. The CEO Mr. Dezhou Wu served as President of ByteDance and has more than 20 years of experience in the smart hardware and consumer goods industry. The company's technology research and development center is located in Denver, Colorado, and the sales mold manufacturing center is located in Beijing, Shenzhen and Dongguan. In October 2021, Well Lead Medical and Sharklet Technologies, Inc. reached a strategic cooperation. The company main business is research and development of advanced manufacturing and new material. The company has a self developed surface texture inhibits bacterial contamination products Sharklet.
Who invested in Sharklet Technologies
2 investors across 2 rounds
See all investors in Sharklet Technologies
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Sharklet Technologies
Who invested in Sharklet Technologies?
Sharklet Technologies has 2 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Sharklet Technologies raised?
Sharklet Technologies has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Sharklet Technologies last raise money?
Sharklet Technologies's most recent round on record is a Series B, in Dec 2012.
What does Sharklet Technologies do?
Established in 2007 and based in Beijing, China,Sharklet Technologies, Inc.
Where is Sharklet Technologies headquartered?
Sharklet Technologies is headquartered in Beijing, China.
Which VCs invest in companies like Sharklet Technologies?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back biotechnology companies at Sharklet Technologies's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Sharklet Technologies? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.